Quantcast

Latest University of Texas MD Anderson Cancer Center Stories

2014-08-19 16:29:12

GILBERT, Ariz., Aug. 19, 2014 /PRNewswire/ -- A cutting-edge research study at Banner MD Anderson Cancer Center is testing the safety and effectiveness of a new investigational drug that, when combined with chemotherapy, may make a major difference in treating breast cancer in patients who carry harmful mutations on either the BRCA1 or BRCA2 genes. The Brocade Study will enroll patients with hereditary breast cancer that is metastatic, meaning it has spread to other parts of the...

2014-08-07 16:28:04

TORONTO, Aug. 7, 2014 /CNW/ - Mr. John Mulvihill, Chair of the Board of Trustees of University Health Network (UHN) and Chair of the Board's Selection Committee for the President & CEO announced today that Dr. Peter Pisters, currently Vice President of The University of Texas MD Anderson Cancer Center's Regional Care System, will serve as UHN's next President & CEO. "I know I speak for everyone on the Board and all members of the Selection Committee when I say how...

2014-07-28 08:29:42

TEMPE, Ariz., July 28, 2014 /PRNewswire/ -- NORVISION, an innovation leader in the digital signage industry, announced its successful implementation of the NORVISION "Skylite" In-ceiling Video-wall. Installed in Banner MD Anderson Cancer Center's radiation rooms, the recessed ceiling screens project calming imagery and serene videos to patients receiving radiation therapy. http://photos.prnewswire.com/prnvar/20140725/130442 "This is the first time this has been done in radiation...

2014-07-25 12:25:13

Joel Helmke Joins as Corporate Vice President of Oncology Services from MD Anderson MARIETTA, Ga., July 25, 2014 /PRNewswire/ -- WellStar Health System is leading the way for cancer care in metro Atlanta. Joel Helmke joins WellStar as corporate vice president of oncology services. He previously held a leadership position at the University of Texas MD Anderson Cancer Center in Houston. At WellStar, Helmke will utilize the System's state-of-the-art technology, innovative physicians...

2014-07-23 12:32:39

HOUSTON, July 23, 2014 /PRNewswire-USNewswire/ -- V. Craig Jordan, Ph.D., one of the world's preeminent breast cancer experts will join The University of Texas MD Anderson Cancer Center this fall. Jordan is considered the "Father of Tamoxifen," the groundbreaking therapeutic drug that has saved countless lives. http://photos.prnewswire.com/prnvar/20140723/129913 As a professor in Breast Medical Oncology and Molecular and Cellular Oncology, Jordan will focus on the new biology of...

2014-05-23 08:24:33

Hundreds of patients and families gain in-depth gastric cancer insights from top oncology and health care experts FORT LAUDERDALE, Fla., May 23, 2014 /PRNewswire/ -- A panel of oncologists and health care experts from leading institutions across the U.S. joined Debbie's Dream Foundation: Curing Stomach Cancer (DDF) in hosting its 4(th) annual Stomach Cancer Education Symposium. The Symposium, supported by Lilly Oncology, convened at 9:00 AM on April 26, 2014. Patients, families, caregivers,...

2014-05-16 08:25:35

BEIJING, May 16, 2014 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced it has engaged The University of Texas MD Anderson Cancer Center ("MD Anderson") as a consultant for its cancer hospital projects under planning in Shanghai and Beijing. According to the...

2014-05-15 08:33:14

FT. LAUDERDALE, Fla., May 15, 2014 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer (DDF) hosted its fifth annual "Dream Makers Gala" on Saturday, April 26(th) at the Fort Lauderdale Marriott Harbor Beach Resort & Spa. With more than 515 people in attendance, the event raised over $300,000 to fund research and benefit stomach cancer patients around the world. Photo - http://photos.prnewswire.com/prnh/20140514/87616 Photo -...

2014-03-27 16:25:04

HOUSTON, March 27, 2014 /PRNewswire-USNewswire/ -- The Susan Poorman Blackie Ovarian Cancer Foundation awarded its first research gift of $125,000 to The University of Texas MD Anderson Cancer Center. Funds will support MD Anderson Cancer Center's Ovarian Moon Shots program, evaluating genetic markers to identify the most effective therapeutic approaches for women with ovarian cancer. A portion of the gift will also be used to help fund innovative research on early detection of...

2014-03-17 08:29:07

HOUSTON, March 17, 2014 /PRNewswire-USNewswire/ -- The University of Texas MD Anderson Cancer Center and MedImmune, the global biologics research and development arm of AstraZeneca, will collaborate through MD Anderson's Moon Shots Program to develop therapies that unleash patients' immune systems to attack their cancers. "Our collaboration with MedImmune, a leader in the field of immunotherapy, will draw on the strengths of both institutions to push ahead for more effective...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.